The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Postprandial Blood Glucose
Open accessAbstract
Individuals with diabetes are at increased risk of developing microvascular complications (retinopathy, nephropathy, and neuropathy) and cardiovascular disease (CVD).The Diabetes Control and Complications Trial (DCCT) (1) and U.K. Prospective Diabetes Study (UKPDS) (2) showed that treatment programs resulting in improved glycemic control, as measured by HbA 1c , reduced the microvascular complications of diabetes.The effect of these treatment programs on reducing CVD was less clear.However, some epidemiological studies suggest that there may be a relationship between glycemic levels and CVD.In the management of diabetes, health care providers usually assess glycemic control with fasting plasma glucose (FPG) and premeal glucose measurements, as well as by measuring HbA 1c .Therapeutic goals for HbA 1c and preprandial glucose levels have been established based on the results of controlled clinical trials.Unfortunately, the majority of patients with diabetes fail to achieve their glycemic goals.Elevated postprandial glucose (PPG) concentrations may contribute to suboptimal glycemic control.Postprandial hyperglycemia is also one of the earliest abnormalities of glucose homeostasis associated with type 2 diabetes and is markedly exaggerated in diabetic patients with fasting hyperglycemia.Several therapies targeted toward lowering PPG excursions are now available and have been shown to improve glycemic control as measured by HbA 1c .However, many questions remain unanswered regarding the definition of PPG and, perhaps most importantly, whether postprandial hyperglycemia has a unique role in the pathogenesis of diabetic complications and should be a specific target of therapy.To address these issues and to provide guidance to health care providers, the American Diabetes Association (ADA) convened a consensus development conference on 24 -26 January 2001 in Atlanta, Georgia.A seven-member panel of experts in diabetes, endocrinology, and metabolism heard selected abstracts and presentations from invited speakers.The panel was then asked to develop a consensus position on the following questions:
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the current consensus of the American Diabetes Association (ADA) is that post-prandial glucose should not necessarily be systematically monitored, and that post-prandial glucose peaks should not necessarily be targeted and corrected [10], although, if monitored, the recommended goal for post-prandial glucose is <10.0 mmol/l (180 mg/dl) [11].”
From Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus (2006) · cites this paper as [10]
In the citing paper
“Elevated postchallenge (2-h oral glucose tolerance test) glucose values have been associated with increased cardiovascular risk independent of fasting plasma glucose in some epidemiologic studies, whereas intervention trials have not shown postprandial glucose to be a cardiovascular risk factor independent of A1C.”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [72]
In the citing paper
“Elevated postchallenge (2-h oral glucose tolerance test) glucose values have been associated with increased cardiovascular risk independent of fasting plasma glucose in some epidemiologic studies, whereas intervention trials have not shown postprandial glucose to be a cardiovascular risk factor independent of A1C.”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Reichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331901 · Cited by 666
Cited by
Sorted by citations
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Self-citationStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Self-citationStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Self-citationStandards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,885
Self-citationMonnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
Standards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190
Self-citationPostprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
Self-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc18-s006 · Cited by 790
Self-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
Self-citation6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
Standards of Medical Care in Diabetes
(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 688
6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s006 · Cited by 655
Self-citationStandards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s33 · Cited by 614
Self-citationFasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Nielsen, L. L., Young, A. A., & Parkes, D. G. (2003) · Regulatory Peptides · doi:10.1016/j.regpep.2003.10.028 · Cited by 459
Esposito, K., Giugliano, D., Nappo, F., & Marfella, R. (2004) · Circulation · doi:10.1161/01.cir.0000134501.57864.66 · Cited by 440
Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties
Livesey, G. (2003) · Nutrition Research Reviews · doi:10.1079/nrr200371 · Cited by 407
Quiescent Fibroblasts Exhibit High Metabolic Activity
Lemons, J. M. S., Feng, X., Bennett, B. D., Legesse-Miller, A., Johnson, E. L., Raitman, I., Pollina, E. A., RABITZ, H. A., Rabinowitz, J. D., & Coller, H. A. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000514 · Cited by 394
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 376
A Novel Approach to Continuous Glucose Analysis Utilizing Glycemic Variation
McDonnell, C. M., Donath, S. M., Vidmar, S., Werther, G. A., & Cameron, F. J. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.253 · Cited by 358
Fineman, M. S., Bicsak, T. A., Shen, L. Z., Taylor, K., Gaines, E., Varns, A., Kim, D. S., & Baron, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2370 · Cited by 351
Evaluation of a New Measure of Blood Glucose Variability in Diabetes
Kovatchev, B. P., Otto, E., Cox, D. J., Gonder-Frederick, L. A., & Clarke, W. L. (2006) · Diabetes Care · doi:10.2337/dc06-1085 · Cited by 344
Gastric emptying in diabetes: clinical significance and treatment
Horowitz, M., O’Donovan, D., Jones, K. L., Feinle, C., Rayner, C. K., & Samsom, M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00658.x · Cited by 308
Hollander, P. A., Levy, P., Fineman, M. S., Maggs, D. G., Shen, L. Z., Strobel, S. A., Weyer, C., & Kolterman, O. G. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.784 · Cited by 307
Glucose metabolism and hyperglycemia
Giugliano, D., Ceriello, A., & Esposito, K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.217s · Cited by 284
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s009 · Cited by 279
Self-citationHollander, P. A., Blonde, L., Rowe, R., Mehta, A., Milburn, J. L., Hershon, K. S., Chiasson, J., Levin, S. R., & for the Exubera Phase III Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2356 · Cited by 265
Standards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s33 · Cited by 264
Self-citationDiabetes control and complications: the role of glycated haemoglobin, 25 years on
Jeffcoate, S. L. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01065.x · Cited by 253
Standards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.1.213 · Cited by 251
Self-citationAmylin Agonists: A Novel Approach in the Treatment of Diabetes
Schmitz, O., Brock, B., & Rungby, J. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s233 · Cited by 237
Plasma Glucose Levels Throughout the Day and HbA1c Interrelationships in Type 2 Diabetes
Bonora, E., Calcaterra, F., Lombardi, S., Bonfante, N., Formentini, G., Bonadonna, R. C., & Muggeo, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2023 · Cited by 235
Service, F. J. (2013) · Diabetes · doi:10.2337/db12-1396 · Cited by 228
Effect of a low-glycemic-index diet during pregnancy on obstetric outcomes
Moses, R. G., Luebcke, M., Davis, W. S., Coleman, K. J., Tapsell, L. C., Petocz, P., & Brand-Miller, J. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.807 · Cited by 219
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
Barr, R. G., Nathan, D. M., Meigs, J., & Singer, D. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-4-200208200-00011 · Cited by 219
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 220
Self-citationGuideline for management of postmeal glucose
Ceriello, A., Colagiuri, S., Gerich, J. E., & Tuomilehto, J. O. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.01.012 · Cited by 211
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s009 · Cited by 205
Self-citationFrancois, M. E., Baldi, J. C., Manning, P. J., Lucas, S. J. E., Hawley, J. A., Williams, M. J. A., & Cotter, J. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3244-6 · Cited by 204
Schwartz, E. A., Koska, J., Mullin, M. P., Syoufi, I., Schwenke, D. C., & Reaven, P. D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.028 · Cited by 173
Vlachos, D., Malisova, S., Lindberg, F. A., & Karaniki, G. (2020) · Nutrients · doi:10.3390/nu12061561 · Cited by 203
Mohamed Sham Shihabudeen, H., Hansi Priscilla, D., & Thirumurugan, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-46 · Cited by 163
The nutrient sensor OGT in PVN neurons regulates feeding
Lagerlöf, O., Slocomb, J. E., Hong, I., Aponte, Y., Blackshaw, S., Hart, G. W., & Huganir, R. L. (2016) · Science · doi:10.1126/science.aad5494 · Cited by 161
Postprandial glucose regulation: New data andnew implications
Leiter, L. A., Ceriello, A., Davidson, J. A., Hanefeld, M., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. O. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.020 · Cited by 160
Tackling Hyperglycemia: A More Comprehensive Approach
Prato, S. D. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.63 · Cited by 160
Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
Jeon, J. Y., Ko, S., Kwon, H., Kim, N. H., Kim, J. H., Kim, C. S., Song, K., Won, J. C., Lim, S. K., Choi, S. H., et al. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.5.349 · Cited by 160
Bode, B., Weinstein, R., Bell, D., McGill, J., Nadeau, D., Raskin, P., Davidson, J., Henry, R., Huang, W.-C., & Reinhardt, R. R. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.439 · Cited by 148
Dairy constituents and neurocognitive health in ageing
Camfield, D., Owen, L., Scholey, A. B., Pipingas, A., & Stough, C. K. K. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511000158 · Cited by 151
Gross, T. M., Kayne, D. M., King, A. B., Rother, C., & Juth, S. E. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503765691848 · Cited by 144
Bonora, E., Corrao, G., Bagnardi, V., Ceriello, A., Comaschi, M., Montanari, P., & Meigs, J. B. (2006) · Diabetologia · doi:10.1007/s00125-006-0203-x · Cited by 141
Ratner, R. E., Want, L. L., Fineman, M. S., Velte, M. J., Ruggles, J. A., Gottlieb, A., Weyer, C., & Kolterman, O. G. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/15209150252924094 · Cited by 156
Villarino, C. B., Jayasena, V., Coorey, R., Chakrabarti-Bell, S., & Johnson, S. K. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.814044 · Cited by 139
What does postprandial hyperglycaemia mean?
Heine, R. J., Balkau, B., Ceriello, A., Prato, S. D., Horton, E. S., & Taskinen, M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01149.x · Cited by 139
Ahmed, N., Babaei‐Jadidi, R., Howell, S. K., Thornalley, P. J., & Beisswenger, P. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2465 · Cited by 137
Contributions of Fasting and Postprandial Glucose to Hemoglobin A1c
Monnier, L., & Colette, C. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.42 · Cited by 135
Hermansen, K., Colombo, M., Storgaard, H., Østergaard, A., Kølendorf, K., & Madsbad, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.883 · Cited by 128
Narrative Review: A Rational Approach to Starting Insulin Therapy
Mooradian, A. D., Bernbaum, M., & Albert, S. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-2-200607180-00010 · Cited by 127
DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results
Buse, J. B., Wolffenbuttel, B. H. R., Herman, W. H., Shemonsky, N. K., Jiang, H. H., Fahrbach, J. L., Scism-Bacon, J. L., & Martin, S. (2009) · Diabetes Care · doi:10.2337/dc08-2117 · Cited by 131
Hyperglycemia during the immediate period after kidney transplantation
Chakkera, H. A., Weil, E. J., Castro, J., Heilman, R. L., Reddy, K. S., Mazur, M. J., Hamawi, K., Mulligan, D. C., Moss, A. A., Mekeel, K. L., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05471008 · Cited by 124
Hirsch, I. B., Bode, B. W., Childs, B. P., Close, K. L., Fisher, W. A., Gavin, J. R., Ginsberg, B. H., Raine, C. H., & Verderese, C. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0104 · Cited by 121
Hyperglycemia and cardiovascular disease
Duckworth, W. C. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0076-x · Cited by 119
Nikbakht, E., Khalesi, S., Singh, I., Williams, L. T., West, N. P., & Colson, N. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1300-3 · Cited by 126
Kohnert, K., Augstein, P., Zander, E., Heinke, P., Peterson, K., Freyse, E., Hovorka, R., & Salzsieder, E. (2009) · Diabetes Care · doi:10.2337/dc08-1956 · Cited by 115
Sato, K. K., Hayashi, T., Harita, N., Yoneda, T., Nakamura, Y., Endo, G., & Kambe, H. (2009) · Diabetes Care · doi:10.2337/dc08-1631 · Cited by 112
Suwa, T., Ohta, A., Matsui, T., Koganei, R., Kato, H., Kawata, T., Sada, Y., ISHII, S., KONDO, A., Murakami, K., et al. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-234 · Cited by 111
Glucokinase activators in diabetes management
Coghlan, M. P., & Leighton, B. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.145 · Cited by 115
The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose
Mudaliar, H., Pollock, C. A., Ma, J., Wu, H., Chadban, S. J., & Panchapakesan, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108844 · Cited by 106
Gingras, V., Taleb, N., Roy‐Fleming, A., Legault, L., & Rabasa‐Lhoret, R. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13052 · Cited by 113
Impact of time since last caloric intake on blood glucose levels
Moebus, S., Göres, L., Lösch, C., & Jöckel, K. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9608-z · Cited by 107
Mendes‐Soares, H., Raveh-Sadka, T., Azulay, S., Ben‐Shlomo, Y., Cohen, Y., Ofek, T., Stevens, J., Bachrach, D., Kashyap, P., Segal, L., et al. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz028 · Cited by 104
Nikolac, N., Šupak Smolčić, V., Šimundić, A.-M., & Ćelap, I. (2013) · Biochemia Medica · doi:10.11613/bm.2013.031 · Cited by 99
Morning Hyperglycemic Excursions
Monnier, L., Colette, C., Rabasa-Lhoret, R., Lapinski, H., Caubel, C., Avignon, A., & Boniface, H. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.737 · Cited by 96
Current Therapeutic Options in Type 2 Diabetes Mellitus: A Practical Approach
Sheehan, M. T. (2003) · Clinical Medicine & Research · doi:10.3121/cmr.1.3.189 · Cited by 96
Pohl, M., Mayr, P., Mertl-Rötzer, M., Lauster, F., Lerch, M., Eriksen, J., Haslbeck, M., & Rahlfs, V. W. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602232 · Cited by 97
Owens, D. R., & Bolli, G. B. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0023 · Cited by 92
Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes
Nielsen, L. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03460-4 · Cited by 93
The Carbohydrate Counting in Adolescents With Type 1 Diabetes (CCAT)Study
Bishop, F. K., Maahs, D. M., Spiegel, G., Owen, D., KLINGENSMITH, G. J., Bortsov, A. V., Thomas, J. M., & Mayer‐Davis, E. J. (2009) · Diabetes Spectrum · doi:10.2337/diaspect.22.1.56 · Cited by 90
Postprandial and Basal Glucose in Type 2 Diabetes: Assessment and Respective Impacts
Monnier, L., Colette, C., & Owens, D. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0239 · Cited by 92
He, H., & Lü, Y. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4019323 · Cited by 87
Diabetes and Cardiovascular Diseases
Kaur, J., Singh, P., & Sowers, J. R. (2002) · American Journal of Therapeutics · doi:10.1097/00045391-200211000-00009 · Cited by 89
Jarvis, P. R. E., Cardin, J. L., Nisevich-Bede, P. M., & McCarter, J. P. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155640 · Cited by 86
Curtis, P. J., Berends, L. M., van der Velpen, V., Jennings, A., Haag, L., Chandra, P., Kay, C. D., Rimm, E. B., & Cassidy, A. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.030 · Cited by 94
O’Connell, M. A., Gilbertson, H., Donath, S. M., & Cameron, F. J. (2008) · Diabetes Care · doi:10.2337/dc08-0306 · Cited by 85
Caputo, S., Pitocco, D., Ruotolo, V., & Ghirlanda, G. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.2011 · Cited by 84
Román‐Carrasco, P., Lieder, B., Somoza, V., Ponce, M., Szépfalusi, Z., Martín, D., Hemmer, W., & Swoboda, I. (2019) · Allergy · doi:10.1111/all.13873 · Cited by 83
Rocha, S., Sousa, A., Ribeiro, D., Correia, C. M., Silva, V. L. M., Santos, C. M. M., Silva, A. M. S., Araújo, A. N., Fernandes, E. G. R., & Freitas, M. (2019) · Food & Function · doi:10.1039/c9fo01298b · Cited by 83
Monnier, L., & Colette, C. (2009) · Diabetes Care · doi:10.2337/dc09-s310 · Cited by 82
American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control*
(2002) · Endocrine Practice · doi:10.4158/ep.8.s1.5 · Cited by 82
Pearce, K. L., Noakes, M., Keogh, J., & Clifton, P. M. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.638 · Cited by 80
Sugars and starch in the nutritional management of diabetes mellitus
Kelley, D. E. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.858s · Cited by 82
Fabozzi, G., Verdone, G., Allori, M., Cimadomo, D., Tatone, C., Stuppia, L., Franzago, M., Ubaldi, N., Vaiarelli, A., Ubaldi, F. M., et al. (2022) · Nutrients · doi:10.3390/nu14091918 · Cited by 101
Targeting postprandial hyperglycemia
Rendell, M., & Jovanovič, L. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.012 · Cited by 80
Yang, J., Campitelli, J., Hu, G., Lin, Y., Luo, J. J., & Xue, C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.040 · Cited by 80
Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
Selvin, E., Rawlings, A. M., Lutsey, P. L., Maruthur, N. M., Pankow, J. S., Steffes, M. W., & Coresh, J. (2015) · Diabetes · doi:10.2337/db15-0607 · Cited by 81
Metadata
- Authors
- Association, A. D.
- Corresponding author
- Association, American Diabetes
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-04-01
- Volume
- 24
- Issue
- 4
- Pages
- 775-778
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4213149640
- Cited by
- 464
- References
- 7
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 21 · 2023: 22 · 2022: 20 · 2021: 22 · 2020: 20 · 2019: 19 · 2018: 17 · 2017: 12 · 2016: 17 · 2015: 15 · 2014: 14 · 2013: 11 · 2012: 16
- FWCI
- 20.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- postprandial blood glucose, postprandial hyperglycemia, glycemic control, type 2 diabetes, HbA1c, glycemic targets, diabetes complications, cardiovascular disease, glucose homeostasis, fasting hyperglycemia, diabetes management
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Fasting, Glycated Hemoglobin, Humans, Hyperglycemia, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
